Diabetes Mellitus, Non-Insulin-Dependent | Patients Attending Clinical Trial Hospital | Residence Clinical Trial Area | Follow-up Regular intended
Item
type 2 diabetic patients attending hospitals or affiliated clinics led by pis of the jade program who are living in the area with an intention to have 'regular' follow-up
boolean
C0011860 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C1999232 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C0019994 (UMLS CUI [2,4])
C0237096 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C0017446 (UMLS CUI [3,3])
C3274571 (UMLS CUI [4,1])
C0205272 (UMLS CUI [4,2])
C1283828 (UMLS CUI [4,3])
Age
Item
aged >18 years
boolean
C0001779 (UMLS CUI [1])
Disease Newly Diagnosed | Disease Established | Lifestyle Therapy | Hypoglycemic Agents | Oral medication | Insulin | Insulin Absent
Item
patients can have newly diagnosed or established disease, treated with lifestyle or blood glucose lowering drugs including oral agents with or without insulin
boolean
C0012634 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0443211 (UMLS CUI [2,2])
C1517876 (UMLS CUI [3])
C0020616 (UMLS CUI [4])
C0175795 (UMLS CUI [5])
C0021641 (UMLS CUI [6])
C0021641 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
Non-Insulin-Dependent Diabetes Mellitus Newly Diagnosed | Plasma glucose level | Plasma fasting glucose measurement Number of occurrences | Plasma random glucose measurement Number of occurrences | Plasma Glucose Measurement Post Oral Glucose Tolerance Test | Hemoglobin A1c measurement
Item
for newly diagnosed type 2 diabetic patients, their plasma glucose levels should be: a) fasting plasma glucose (pg) >7.0 mmol/l on 2 or more occasions, and/or b) random (or post-ogtt 2h) pg >11.1 mmol/l on 2 or more occasions, and/or c) hba1c >6.5%
boolean
C0011860 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0455280 (UMLS CUI [2])
C0583513 (UMLS CUI [3,1])
C0449789 (UMLS CUI [3,2])
C0583512 (UMLS CUI [4,1])
C0449789 (UMLS CUI [4,2])
C0202042 (UMLS CUI [5,1])
C0687676 (UMLS CUI [5,2])
C0029161 (UMLS CUI [5,3])
C0474680 (UMLS CUI [6])
Diabetes Mellitus, Insulin-Dependent | Ketosis | Symptoms Ketonuria Severe | Symptoms Ketoacidosis | Requirement Insulin
Item
type 1 diabetes defined as a history of ketosis at diagnosis [acute symptoms with heavy ketonuria (>3+) or ketoacidosis] or continuous requirement of insulin within one year of diagnosis
boolean
C0011854 (UMLS CUI [1])
C0022638 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0162275 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C1457887 (UMLS CUI [4,1])
C0220982 (UMLS CUI [4,2])
C1514873 (UMLS CUI [5,1])
C0021641 (UMLS CUI [5,2])
Reduced life expectancy Due to Advanced cancer | Condition Life Threatening
Item
patients with reduced life expectancy (e.g. less than 6-months) due to recent diagnosis of advanced cancers (e.g. within last 2 years) and other life threatening conditions
boolean
C1858274 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0877373 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2826244 (UMLS CUI [2,2])
Study Protocol Comprehension Unable | Etiology Mental condition
Item
patients with a mental condition rendering them unable to understand the nature, scope, and possible consequences of the study
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C3840291 (UMLS CUI [2,2])
Study Subject Participation Status | Interventional Study
Item
patients actively enrolled in another intervention study
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
Follow-up Regular Unwilling
Item
patients who are unwilling to return for regular follow up
boolean
C3274571 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])